Annual Total Long Term Liabilities
$0.00
-$65.00 K-100.00%
31 December 2023
Summary:
Titan Pharmaceuticals annual total long term liabilities is currently $0.00, with the most recent change of -$65.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$332.00 thousand (-100.00%). TTNP annual total long term liabilities is now -100.00% below its all-time high of $26.56 million, reached on 31 December 2012.TTNP Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly total long term liabilities is currently $0.00, unchanged on 30 June 2024. Over the past year, it has stayed the same.TTNP quarterly long term liabilities is now -100.00% below its all-time high of $26.98 million, reached on 30 September 2012.TTNP Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
TTNP Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -100.0% | ||
| 5 y | 5 years | -100.0% | -100.0% | ||
| alltime | all time | -100.0% | -100.0% |
Titan Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $33.00 K(-49.2%) |
| Dec 2022 | $65.00 K(-65.2%) | $65.00 K(-32.3%) |
| Sept 2022 | - | $96.00 K(-25.0%) |
| June 2022 | - | $128.00 K(-19.0%) |
| Mar 2022 | - | $158.00 K(-15.5%) |
| Dec 2021 | $187.00 K(-43.7%) | $187.00 K(-13.4%) |
| Sept 2021 | - | $216.00 K(-11.5%) |
| June 2021 | - | $244.00 K(+177.3%) |
| Mar 2021 | - | $88.00 K(-73.5%) |
| Dec 2020 | $332.00 K(-92.6%) | $332.00 K(-89.1%) |
| Sept 2020 | - | $3.04 M(-9.2%) |
| June 2020 | - | $3.35 M(-6.5%) |
| Mar 2020 | - | $3.58 M(-20.3%) |
| Dec 2019 | $4.49 M(+17.8%) | $4.49 M(+0.2%) |
| Sept 2019 | - | $4.48 M(+49.9%) |
| June 2019 | - | $2.99 M(-17.5%) |
| Mar 2019 | - | $3.62 M(-4.9%) |
| Dec 2018 | $3.81 M(+6.4%) | $3.81 M(-8.4%) |
| Sept 2018 | - | $4.16 M(+17.6%) |
| June 2018 | - | $3.54 M(+3.6%) |
| Mar 2018 | - | $3.42 M(-4.6%) |
| Dec 2017 | $3.58 M(+479.0%) | $3.58 M(-46.7%) |
| Sept 2017 | - | $6.73 M(>+9900.0%) |
| June 2017 | - | $7000.00(-96.4%) |
| Mar 2017 | - | $197.00 K(-68.2%) |
| Dec 2016 | $619.00 K(-57.1%) | $619.00 K(-60.2%) |
| Sept 2016 | - | $1.55 M(+0.3%) |
| June 2016 | - | $1.55 M(+7.6%) |
| Mar 2016 | - | $1.44 M(-0.3%) |
| Dec 2015 | $1.44 M(-74.1%) | $1.44 M(+3.3%) |
| Sept 2015 | - | $1.40 M(-86.1%) |
| June 2015 | - | $10.04 M(+13.4%) |
| Mar 2015 | - | $8.86 M(+58.8%) |
| Dec 2014 | $5.58 M(+207.0%) | $5.58 M(+270.9%) |
| Sept 2014 | - | $1.50 M(-49.3%) |
| June 2014 | - | $2.96 M(+10.6%) |
| Mar 2014 | - | $2.68 M(+47.6%) |
| Dec 2013 | $1.82 M(-93.2%) | $1.82 M(-19.2%) |
| Sept 2013 | - | $2.25 M(+81.7%) |
| June 2013 | - | $1.24 M(-81.3%) |
| Mar 2013 | - | $6.60 M(-75.2%) |
| Dec 2012 | $26.56 M(+5.5%) | $26.56 M(-1.6%) |
| Sept 2012 | - | $26.98 M(+14.4%) |
| June 2012 | - | $23.59 M(-6.8%) |
| Mar 2012 | - | $25.31 M(+0.6%) |
| Dec 2011 | $25.17 M(+366.2%) | $25.17 M(+42.1%) |
| Sept 2011 | - | $17.72 M(-9.7%) |
| June 2011 | - | $19.62 M(+298.0%) |
| Mar 2011 | - | $4.93 M(-8.7%) |
| Dec 2010 | $5.40 M | $5.40 M(-11.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $6.11 M(+232.0%) |
| June 2010 | - | $1.84 M(-13.1%) |
| Mar 2010 | - | $2.12 M(-11.2%) |
| Dec 2009 | $2.39 M(>+9900.0%) | $2.39 M(+1939.3%) |
| Sept 2008 | - | $117.00 K(-44.5%) |
| June 2008 | - | $211.00 K(>+9900.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2007 | - | $0.00(0.0%) |
| June 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2006 | - | $0.00(0.0%) |
| June 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2005 | - | $0.00(0.0%) |
| June 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2004 | - | $0.00(0.0%) |
| June 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2003 | - | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(0.0%) |
| Dec 2001 | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2001 | - | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00(-100.0%) |
| Dec 1999 | $100.00 K(>+9900.0%) | $100.00 K(>+9900.0%) |
| Sept 1999 | - | $0.00(-100.0%) |
| June 1999 | - | $100.00 K(>+9900.0%) |
| Mar 1999 | - | $0.00(0.0%) |
| Dec 1998 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 1998 | - | $0.00(-100.0%) |
| June 1998 | - | $100.00 K(>+9900.0%) |
| Mar 1998 | - | $0.00(-100.0%) |
| Dec 1997 | $5.50 M(+323.1%) | $5.50 M(0.0%) |
| Sept 1997 | - | $5.50 M(0.0%) |
| June 1997 | - | $5.50 M(-15.4%) |
| Mar 1997 | - | $6.50 M(+400.0%) |
| Dec 1996 | $1.30 M(-31.6%) | $1.30 M(-13.3%) |
| Sept 1996 | - | $1.50 M(-6.3%) |
| June 1996 | - | $1.60 M(-11.1%) |
| Mar 1996 | - | $1.80 M(-5.3%) |
| Dec 1995 | $1.90 M | $1.90 M |
FAQ
- What is Titan Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Titan Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Titan Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of TTNP is $0.00
What is the all time high annual total long term liabilities for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual total long term liabilities is $26.56 M
What is Titan Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, TTNP annual total long term liabilities has changed by -$65.00 K (-100.00%)
What is Titan Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of TTNP is $0.00
What is the all time high quarterly long term liabilities for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly total long term liabilities is $26.98 M
What is Titan Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, TTNP quarterly total long term liabilities has changed by $0.00 (0.00%)